(R)-N-(4-(1-(2-(dimethylamino)-7-methylquinazolin-4-ylamino)ethyl)phenyl)-4-fluorobenzamide

ID: ALA3900119

PubChem CID: 68939726

Max Phase: Preclinical

Molecular Formula: C26H26FN5O

Molecular Weight: 443.53

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  Cc1ccc2c(N[C@H](C)c3ccc(NC(=O)c4ccc(F)cc4)cc3)nc(N(C)C)nc2c1

Standard InChI:  InChI=1S/C26H26FN5O/c1-16-5-14-22-23(15-16)30-26(32(3)4)31-24(22)28-17(2)18-8-12-21(13-9-18)29-25(33)19-6-10-20(27)11-7-19/h5-15,17H,1-4H3,(H,29,33)(H,28,30,31)/t17-/m1/s1

Standard InChI Key:  FDQIPUBUNUJHCQ-QGZVFWFLSA-N

Molfile:  

     RDKit          2D

 33 36  0  0  0  0  0  0  0  0999 V2000
   22.8054   -4.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1004   -4.7814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1004   -5.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3913   -6.0072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6822   -5.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6822   -4.7814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.3913   -4.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8054   -3.5556    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   23.5145   -4.7814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.9732   -6.0072    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   24.2194   -4.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2194   -3.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9285   -3.1470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6376   -3.5556    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6376   -4.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9285   -4.7814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3467   -3.1470    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3467   -2.3298    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.0517   -3.5556    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0517   -6.0072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.3467   -5.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.3467   -4.7814    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   27.0517   -4.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7608   -4.7814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4657   -4.3728    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1748   -4.7814    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.1748   -5.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.4657   -6.0072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.7608   -5.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.8839   -6.0072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.6376   -6.0072    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.6376   -6.8244    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.9285   -5.5986    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  2  7  2  0
  1  8  2  0
  1  9  1  0
  5 10  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 11 16  2  0
 17 18  1  1
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 20 29  2  0
 24 29  1  0
 27 30  1  0
 31 32  1  0
 31 33  1  0
 21 31  1  0
 19 23  1  0
 17 19  1  0
 14 17  1  0
  9 11  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA3900119

   N-[4-[(1R)-1-[[2-(dimethylamino)-7-methylquinazolin-4-yl]amino]ethyl]phenyl]-4-fluorobenzamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 443.53

Molecular Weight (Monoisotopic): 443.2121

AlogP: 5.57

#Rotatable Bonds: 6

Polar Surface Area: 70.15

Molecular Species: NEUTRAL

HBA: 5

HBD: 2

#RO5 Violations: 1

HBA (Lipinski): 6

HBD (Lipinski): 2

#RO5 Violations (Lipinski): 1

CX Acidic pKa: ┄

CX Basic pKa: 6.99

CX LogP: 6.17

CX LogD: 6.03

Aromatic Rings: 4

Heavy Atoms: 33

QED Weighted: 0.41

Np Likeness Score: -1.72

References

1.  (2009)  Amino-substituted quinazoline derivatives as inhibitors of Beta-catenin/TCF-4 pathway and cancer treatment agents, 

Source

Source(1):

• Patent Bioactivity Data